Showing results (1341-1350 of 1,352) with videos related to
Sort By:
Pageof 136
The Lancet. Respiratory Medicine|June 12, 2022
Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trialRolando Ochoa-Azze, Arturo Chang-Monteagudo, Yanet Climent-Ruiz, et al.Sensors (Basel, Switzerland)|July 18, 2018
SiCILIA-Silicon Carbide Detectors for Intense Luminosity Investigations and ApplicationsSalvatore Tudisco, Francesco La Via, Clementina Agodi, et al.Immunity|November 11, 2018
Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant AcceptanceMounia S Braza, Mandy M T van Leent, Marnix Lameijer, et al.Nature Nanotechnology|July 31, 2024
Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapyAnnelies C Wauters, Jari F Scheerstra, Mandy M T van Leent, et al.BMC Infectious Diseases|November 24, 2022
Convalescent or standard plasma versus standard of care in the treatment of COVID-19 patients with respiratory impairment: short and long-term effects. A three-arm randomized controlled clinical trialPaola Maria Manzini, Giovannino Ciccone, Francesco Giuseppe De Rosa, et al.Cell|October 30, 2020
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint InhibitionBram Priem, Mandy M T van Leent, Abraham J P Teunissen, et al.Cancers|December 29, 2020
Performance of Comprehensive Complication Index and Clavien-Dindo Complication Scoring System in Liver Surgery for Hepatocellular CarcinomaAlessandro Giani, Federica Cipriani, Simone Famularo, et al.Lancet Regional Health. Americas|January 30, 2023
Risk of adverse outcomes in offspring with RT-PCR confirmed prenatal Zika virus exposure: An individual participant data meta-analysis of 13 cohorts in the Zika Brazilian Cohorts ConsortiumRicardo Arraes de Alencar Ximenes, Demócrito de Barros Miranda-Filho, Elizabeth B Brickley, et al.Pediatric Pulmonology|May 15, 2003
Palivizumab prophylaxis of respiratory syncytial virus disease in 2000-2001: results from The Palivizumab Outcomes RegistryCurt Parnes, Judith Guillermin, Rolf Habersang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2005
Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly studyPaolo Maione, Francesco Perrone, Ciro Gallo, et al.Pageof 136